U.S Physical Therapy Basic EPS 2010-2025 | USPH

U.S Physical Therapy basic eps from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
U.S Physical Therapy Annual Basic EPS
2024 $1.84
2023 $1.28
2022 $2.25
2021 $2.41
2020 $2.48
2019 $2.45
2018 $1.31
2017 $1.76
2016 $1.64
2015 $1.66
2014 $1.57
2013 $1.05
2012 $1.52
2011 $1.78
2010 $1.34
2009 $1.01
U.S Physical Therapy Quarterly Basic EPS
2025-03-31 $0.80
2024-12-31 $0.52
2024-09-30 $0.39
2024-06-30 $0.47
2024-03-31 $0.46
2023-12-31 $-0.45
2023-09-30 $0.51
2023-06-30 $0.64
2023-03-31 $0.58
2022-12-31 $-0.01
2022-09-30 $0.72
2022-06-30 $0.87
2022-03-31 $0.67
2021-12-31 $0.72
2021-09-30 $0.66
2021-06-30 $0.82
2021-03-31 $0.21
2020-12-31 $0.68
2020-09-30 $0.61
2020-06-30 $0.99
2020-03-31 $0.20
2019-12-31 $0.55
2019-09-30 $0.66
2019-06-30 $0.85
2019-03-31 $0.39
2018-12-31 $0.43
2018-09-30 $0.13
2018-06-30 $0.48
2018-03-31 $0.27
2017-12-31 $0.58
2017-09-30 $0.41
2017-06-30 $0.39
2017-03-31 $0.38
2016-12-31 $0.42
2016-09-30 $0.38
2016-06-30 $0.48
2016-03-31 $0.36
2015-12-31 $0.37
2015-09-30 $0.47
2015-06-30 $0.48
2015-03-31 $0.34
2014-12-31 $0.35
2014-09-30 $0.43
2014-06-30 $0.52
2014-03-31 $0.27
2013-12-31 $0.31
2013-09-30 $0.02
2013-06-30 $0.41
2013-03-31 $0.31
2012-12-31 $0.34
2012-09-30 $0.39
2012-06-30 $0.41
2012-03-31 $0.38
2011-12-31 $0.69
2011-09-30 $0.35
2011-06-30 $0.42
2011-03-31 $0.32
2010-12-31 $0.36
2010-09-30 $0.33
2010-06-30 $0.38
2010-03-31 $0.27
2009-12-31 $0.20
2009-09-30 $0.27
2009-06-30 $0.31
2009-03-31 $0.23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.124B $0.671B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.633B 18.36
Encompass Health (EHC) United States $11.089B 23.51
DaVita (DVA) United States $10.658B 14.98
Elanco Animal Health (ELAN) United States $7.340B 15.72
Chemed (CHE) United States $6.602B 20.75
Option Care Health (OPCH) United States $4.827B 21.52
RadNet (RDNT) United States $4.313B 273.76
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $1.969B 21.62
LifeStance Health (LFST) United States $1.641B 0.00
Astrana Health (ASTH) United States $1.270B 31.46
Pennant (PNTG) United States $0.808B 29.66
Aveanna Healthcare Holdings (AVAH) United States $0.773B 44.00
Atai Life Sciences (ATAI) Germany $0.647B 0.00
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00